|
CN101502698A
|
|
Electric needle and electric stimulation therapeutic equipment capable of outputting various waveforms
|
|
CN101444623A
|
|
Vaccine adjuvant
|
|
CN101502657A
|
|
Method for constructing phage vector vaccine fused with gp350 protein of EB virus
|
|
CN101327323A
|
|
Lyophilization technique for preparing lyophilized hepatitis A attenuated live vaccine
|
|
CN101307314A
|
|
Method for constructing and preparing vaccine against type 2 diabetes mellitus
|
|
CN101215552A
|
|
F-genetype parotitis attenuated virus strain and use thereof
|
|
CN1943784A
|
|
New vaccine adjuvant
|
|
CN1966075A
|
|
Method for preparing inactivated vaccine of encephalitis B used for human being
|
|
CN1843509A
|
|
Freeze-drying hepatitis A attenuated live vaccine and its preparation method
|
|
CN101099862A
|
|
Inactivated vaccine for preventing monkey from SV40 virus infection and preparation method
|
|
CN1772920A
|
|
Fast and sensitive method of detecting virus infection titer of attenuated live hepatitis A vaccine
|
|
CN1637140A
|
|
Method of culturing and propagating poliomyelitis virus with human embryo lung diploid
|
|
CN1616096A
|
|
Method for cultivating attenuated strain pilio inactivated vaccine
|
|
CN1616095A
|
|
After treatment method for attenuated strain polio inactivated vaccine
|
|
CN1506377A
|
|
Human granulocyte-macrophage colony stimulating factor/interleukin-6 fusion protein and its construction process
|
|
CN1385440A
|
|
Protein molecule with function for inhibiting I type simple herpesvirus replication and its preparation method
|
|
CN1320424A
|
|
Application of sodium 3,4-dihydroxycinnamate in preparing antineoplastics
|
|
CN1314415A
|
|
Human connective tissue growing factor and its preparing method
|
|
CN1247091A
|
|
Freeze-dired attenuated live vaccine for hepatitis A and its preparing process
|
|
CN1101941A
|
|
Method for suspending, adsorbing and multiplicating virus of hepatitis A
|
